143 related articles for article (PubMed ID: 31890735)
1. Low-Dose Busulfan Reduces Human CD34
Leonard A; Yapundich M; Nassehi T; Gamer J; Drysdale CM; Haro-Mora JJ; Demirci S; Hsieh MM; Uchida N; Tisdale JF
Mol Ther Methods Clin Dev; 2019 Dec; 15():430-437. PubMed ID: 31890735
[TBL] [Abstract][Full Text] [Related]
2. Nonirradiated NOD,B6.SCID Il2rγ-/- Kit(W41/W41) (NBSGW) mice support multilineage engraftment of human hematopoietic cells.
McIntosh BE; Brown ME; Duffin BM; Maufort JP; Vereide DT; Slukvin II; Thomson JA
Stem Cell Reports; 2015 Feb; 4(2):171-80. PubMed ID: 25601207
[TBL] [Abstract][Full Text] [Related]
3. Busulfan produces efficient human cell engraftment in NOD/LtSz-Scid IL2Rgamma(null) mice.
Hayakawa J; Hsieh MM; Uchida N; Phang O; Tisdale JF
Stem Cells; 2009 Jan; 27(1):175-82. PubMed ID: 18927475
[TBL] [Abstract][Full Text] [Related]
4. Development of LT-HSC-Reconstituted Non-Irradiated NBSGW Mice for the Study of Human Hematopoiesis
Adigbli G; Hua P; Uchiyama M; Roberts I; Hester J; Watt SM; Issa F
Front Immunol; 2021; 12():642198. PubMed ID: 33868276
[TBL] [Abstract][Full Text] [Related]
5. Intra-bone marrow transplantation of human CD34(+) cells into NOD/LtSz-scid IL-2rgamma(null) mice permits multilineage engraftment without previous irradiation.
Bueno C; Montes R; de la Cueva T; Gutierrez-Aránda I; Menendez P
Cytotherapy; 2010; 12(1):45-9. PubMed ID: 19929453
[TBL] [Abstract][Full Text] [Related]
6. Transient and permanent engraftment potential of murine hematopoietic stem cell subsets: differential effects of host conditioning with gamma radiation and cytotoxic drugs.
Down JD; Ploemacher RE
Exp Hematol; 1993 Jul; 21(7):913-21. PubMed ID: 8100536
[TBL] [Abstract][Full Text] [Related]
7. An assay for long-term engrafting human hematopoietic cells based on newborn NOD/SCID/beta2-microglobulin(null) mice.
Ishikawa F; Livingston AG; Wingard JR; Nishikawa Si; Ogawa M
Exp Hematol; 2002 May; 30(5):488-94. PubMed ID: 12031656
[TBL] [Abstract][Full Text] [Related]
8. Comparison of different busulfan analogues for depletion of hematopoietic stem cells and promotion of donor-type chimerism in murine bone marrow transplant recipients.
Westerhof GR; Ploemacher RE; Boudewijn A; Blokland I; Dillingh JH; McGown AT; Hadfield JA; Dawson MJ; Down JD
Cancer Res; 2000 Oct; 60(19):5470-8. PubMed ID: 11034090
[TBL] [Abstract][Full Text] [Related]
9. Conditions that enable human hematopoietic stem cell engraftment in all NOD-SCID mice.
Rice AM; Wood JA; Milross CG; Collins CJ; McCarthy NF; Vowels MR
Transplantation; 2000 Mar; 69(5):927-35. PubMed ID: 10755552
[TBL] [Abstract][Full Text] [Related]
10. Ex vivo culture of cord blood CD34+ cells expands progenitor cell numbers, preserves engraftment capacity in nonobese diabetic/severe combined immunodeficient mice, and enhances retroviral transduction efficiency.
Novelli EM; Cheng L; Yang Y; Leung W; Ramírez M; Tanavde V; Enger C; Civin CI
Hum Gene Ther; 1999 Dec; 10(18):2927-40. PubMed ID: 10609654
[TBL] [Abstract][Full Text] [Related]
11. A novel immunodeficient mouse model--RAG2 x common cytokine receptor gamma chain double mutants--requiring exogenous cytokine administration for human hematopoietic stem cell engraftment.
Mazurier F; Fontanellas A; Salesse S; Taine L; Landriau S; Moreau-Gaudry F; Reiffers J; Peault B; Di Santo JP; de Verneuil H
J Interferon Cytokine Res; 1999 May; 19(5):533-41. PubMed ID: 10386866
[TBL] [Abstract][Full Text] [Related]
12. An assay for human hematopoietic stem cells based on transplantation into nonobese diabetic recombination activating gene-null perforin-null mice.
Minamiguchi H; Wingard JR; Laver JH; Mainali ES; Shultz LD; Ogawa M
Biol Blood Marrow Transplant; 2005 Jul; 11(7):487-94. PubMed ID: 15983548
[TBL] [Abstract][Full Text] [Related]
13. The effect of human fetal liver-derived mesenchymal stem cells on CD34+ hematopoietic stem cell repopulation in NOD/Shi-scid/IL-2Rã(null) mice.
Yang HM; Cho MR; Sung JH; Yang SJ; Nam MH; Roh CR; Kim JM; Shin M; Song SH; Kwon CH; Joh JW; Kim SJ
Transplant Proc; 2011 Jun; 43(5):2004-8. PubMed ID: 21693316
[TBL] [Abstract][Full Text] [Related]
14. Transplantation with selected autologous peripheral blood CD34+Thy1+ hematopoietic stem cells (HSCs) in multiple myeloma: impact of HSC dose on engraftment, safety, and immune reconstitution.
Michallet M; Philip T; Philip I; Godinot H; Sebban C; Salles G; Thiebaut A; Biron P; Lopez F; Mazars P; Roubi N; Leemhuis T; Hanania E; Reading C; Fine G; Atkinson K; Juttner C; Coiffier B; Fière D; Archimbaud E
Exp Hematol; 2000 Jul; 28(7):858-70. PubMed ID: 10907648
[TBL] [Abstract][Full Text] [Related]
15. [The observation of engraftment of human umbilical cord blood-derived hematopoietic stem/progenitor cells in xenotransplanted NOD/SCID mouse model by intra-bone marrow injection].
Gao JT; Lu SH; Li YH; Yang Z; Xu J; Zheng YZ
Zhonghua Xue Ye Xue Za Zhi; 2008 Jun; 29(6):361-5. PubMed ID: 19031735
[TBL] [Abstract][Full Text] [Related]
16. Bone Marrow Transplantation after Nonmyeloablative Treosulfan Conditioning Is Curative in a Murine Model of Sickle Cell Disease.
Devadasan D; Sun CW; Westin ER; Wu LC; Pawlik KM; Townes TM; Goldman FD
Biol Blood Marrow Transplant; 2018 Aug; 24(8):1554-1562. PubMed ID: 29684562
[TBL] [Abstract][Full Text] [Related]
17. CD26 inhibition on CD34+ or lineage- human umbilical cord blood donor hematopoietic stem cells/hematopoietic progenitor cells improves long-term engraftment into NOD/SCID/Beta2null immunodeficient mice.
Christopherson KW; Paganessi LA; Napier S; Porecha NK
Stem Cells Dev; 2007 Jun; 16(3):355-60. PubMed ID: 17610365
[TBL] [Abstract][Full Text] [Related]
18. Cord blood CD34+ cells expanded on Wharton's jelly multipotent mesenchymal stromal cells improve the hematopoietic engraftment in NOD/SCID mice.
Milazzo L; Vulcano F; Barca A; Macioce G; Paldino E; Rossi S; Ciccarelli C; Hassan HJ; Giampaolo A
Eur J Haematol; 2014 Nov; 93(5):384-91. PubMed ID: 24797266
[TBL] [Abstract][Full Text] [Related]
19. Early-acting cytokine-driven ex vivo expansion of mobilized peripheral blood CD34+ cells generates post-mitotic offspring with preserved engraftment ability in non-obese diabetic/severe combined immunodeficient mice.
Herrera C; Sánchez J; Torres A; Bellido C; Rueda A; Alvarez MA
Br J Haematol; 2001 Sep; 114(4):920-30. PubMed ID: 11564087
[TBL] [Abstract][Full Text] [Related]
20. Enhanced engraftment of human cells in RAG2/gammac double-knockout mice after treatment with CL2MDP liposomes.
Rozemuller H; Knaän-Shanzer S; Hagenbeek A; van Bloois L; Storm G; Martens AC
Exp Hematol; 2004 Nov; 32(11):1118-25. PubMed ID: 15539091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
